Robert J. Bitterman - Nov 25, 2022 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Interim Executive Chairman, Director
Signature
Caitlin Kontulis, attorney-in-fact
Stock symbol
PHIO
Transactions as of
Nov 25, 2022
Transactions value $
$1,136
Form type
4
Date filed
11/29/2022, 03:30 PM
Previous filing
Nov 16, 2022
Next filing
Dec 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $1.05K +2.5K +3.8% $0.42 68.3K Nov 25, 2022 Direct F1
transaction PHIO Common stock, $0.0001 par value Purchase $86.00 +215 +0.31% $0.40 68.5K Nov 29, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.